- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 31,971,491
- Share change
- +2,283,740
- Total reported value
- $1,640,380,010
- Put/Call ratio
- 90%
- Price per share
- $51.31
- Number of holders
- 179
- Value change
- +$123,898,647
- Number of buys
- 105
- Number of sells
- 57
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bellevue Group AG |
13F
|
Company |
1.9%
|
5,037,890
|
$158,844,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.96%
|
2,480,112
|
$78,196,000 | — | 31 Mar 2020 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.89%
|
2,313,022
|
$72,930,000 | — | 31 Mar 2020 | |
| Meditor Group Ltd |
13F
|
Company |
1%
|
2,679,835
|
$68,144,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.76%
|
1,953,987
|
$61,610,000 | — | 31 Mar 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.51%
|
1,323,947
|
$41,744,000 | — | 31 Mar 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.43%
|
1,106,617
|
$34,892,000 | — | 31 Mar 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
0.38%
|
975,000
|
$30,742,000 | — | 31 Mar 2020 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.35%
|
906,336
|
$28,577,000 | — | 31 Mar 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.34%
|
891,706
|
$28,116,000 | — | 31 Mar 2020 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.31%
|
811,692
|
$25,593,000 | — | 31 Mar 2020 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.23%
|
592,798
|
$18,691,000 | — | 31 Mar 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.08%
|
215,096
|
$12,538,000 | — | 31 Mar 2020 | |
| ROTHSCHILD & CO ASSET MANAGEMENT US INC. |
13F
|
Company |
0.15%
|
387,583
|
$12,220,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
371,416
|
$11,710,000 | — | 31 Mar 2020 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.14%
|
355,328
|
$11,203,000 | — | 31 Mar 2020 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.12%
|
318,352
|
$10,038,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
313,923
|
$9,898,000 | — | 31 Mar 2020 | |
| NORGES BANK |
13F
|
Company |
0.12%
|
313,569
|
$9,887,000 | — | 31 Mar 2020 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.1%
|
269,513
|
$8,498,000 | — | 31 Mar 2020 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.1%
|
261,738
|
$8,253,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
236,886
|
$7,469,000 | — | 31 Mar 2020 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.09%
|
230,454
|
$7,266,000 | — | 31 Mar 2020 | |
| NOMURA HOLDINGS INC |
13F
|
Company |
0.09%
|
225,000
|
$7,082,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0.08%
|
207,529
|
$6,543,000 | — | 31 Mar 2020 | |
| Avidity Partners Management LP |
13F
|
Company |
0.08%
|
205,000
|
$6,464,000 | — | 31 Mar 2020 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.08%
|
202,631
|
$6,460,000 | — | 31 Mar 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.08%
|
200,842
|
$6,333,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
190,067
|
$5,993,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
188,929
|
$5,957,000 | — | 31 Mar 2020 | |
| BAMCO INC /NY/ |
13F
|
Company |
0.07%
|
188,500
|
$5,943,000 | — | 31 Mar 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.07%
|
184,347
|
$5,813,000 | — | 31 Mar 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.07%
|
183,731
|
$5,794,000 | — | 31 Mar 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
179,208
|
$5,650,000 | — | 31 Mar 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
178,935
|
$5,641,000 | — | 31 Mar 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
137,238
|
$4,327,000 | — | 31 Mar 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.05%
|
135,561
|
$4,275,000 | — | 31 Mar 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.04%
|
111,725
|
$3,523,000 | — | 31 Mar 2020 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.04%
|
105,439
|
$3,324,000 | — | 31 Mar 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.04%
|
103,808
|
$3,273,000 | — | 31 Mar 2020 | |
| PDT Partners, LLC |
13F
|
Company |
0.04%
|
103,567
|
$3,265,000 | — | 31 Mar 2020 | |
| BAILARD, INC. |
13F
|
Company |
0.04%
|
93,300
|
$2,942,000 | — | 31 Mar 2020 | |
| MOODY ALDRICH PARTNERS LLC |
13F
|
Company |
0.03%
|
88,760
|
$2,799,000 | — | 31 Mar 2020 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.03%
|
86,484
|
$2,727,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
86,423
|
$2,725,000 | — | 31 Mar 2020 | |
| Nicholas Investment Partners, LP |
13F
|
Company |
0.03%
|
86,118
|
$2,715,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.03%
|
85,165
|
$2,685,000 | — | 31 Mar 2020 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.03%
|
80,600
|
$2,541,000 | — | 31 Mar 2020 | |
| GAM Holding AG |
13F
|
Company |
0.03%
|
70,700
|
$2,229,000 | — | 31 Mar 2020 | |
| ClariVest Asset Management LLC |
13F
|
Company |
0.02%
|
62,922
|
$1,983,000 | — | 31 Mar 2020 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q2 2020
As of 30 Jun 2020,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
179 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,971,491 shares.
The largest 10 holders included
Bellevue Group AG, Meditor Group Ltd, VANGUARD GROUP INC, Pentwater Capital Management LP, BlackRock Inc., STATE STREET CORP, MARSHALL WACE, LLP, WASATCH ADVISORS INC, BOXER CAPITAL, LLC, and CREDIT SUISSE AG/.
This page lists
179
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
157
Q2 2020 holders
179
Holder diff
22
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.